Study Design
Subject Type
Human
Trial Design
Double-Blind, Controlled
Trial Duration
84 days
Participants
30 (23 completed)
Age Range
25-47 years
Efficacy
Intervention(s) Outcome
Melasma
Sign in to read for free
Melasma
Sign in to read for free
Side Effects
Intervention(s) Outcome
Irritation
Sign in to read for free
Irritation
Sign in to read for free
Study Summary
Sign in to read for free